Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
BOLD
BOLD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BOLD News
Boundless Bio Q4 Earnings Miss Expectations
2d ago
seekingalpha
Analysis of Growth Drivers in the Biliary Tract Cancer Market
Mar 02 2026
Newsfilter
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
Aug 05 2025
Newsfilter
Rice Biotech Launch Pad welcomes Carolyn Ng to external advisory board
Jul 31 2025
Newsfilter
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Jun 05 2025
Newsfilter
Leerink Partners Downgrades Boundless Bio to Market Perform, Lowers Price Target to $3
May 28 2025
Benzinga
Boundless Bio Announces Portfolio Prioritization and Runway Extension
May 23 2025
Newsfilter
Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)
Mar 30 2025
Business Insider
Boundless Bio Appoints Robert Doebele As Chief Medical Officer
Feb 03 2025
NASDAQ.COM
Boundless Bio Announces Pipeline and Leadership Updates
Dec 12 2024
Newsfilter
Boundless Bio Announces Pipeline and Leadership Updates
Dec 12 2024
Yahoo Finance
Boundless Bio CFO Jami Rubin Steps Down For Personal Reasons
Oct 14 2024
NASDAQ.COM
Boundless Bio Announces Departure of Chief Financial Officer
Oct 14 2024
Newsfilter
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
Sep 11 2024
Newsfilter
Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out
Aug 18 2024
NASDAQ.COM
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
Aug 13 2024
Business Insider
Show More News
